AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Liabilities and Shareholders Equity (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly Liabilities and Shareholders Equity of $264.9 million for Q1 2026, down 9.51% quarter-over-quarter from $292.7 million in Q4 2025.

Analysis

AtaiBeckley (ATAI) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

AtaiBeckley's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $264.9 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $264.9 million; the TTM figure through Mar 2026 stood at $717.0 million (changed N/A YoY), while the FY2025 annual figure was $292.7 million, up 83.66% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $264.9 million, down from $292.7 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $342.6 million in Q3 2022 and troughed at $885000.0 in Q1 2021.
  • A 5-year average of $178.6 million and a median of $239.8 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Peak annual rise in Liabilities and Shareholders Equity reached 83.66% in 2025, while the deepest fall reached 83.66% in 2025.
  • AtaiBeckley's Liabilities and Shareholders Equity stood at $159.4 million in 2024, then soared by 83.66% to $292.7 million in 2025, then decreased by 9.51% to $264.9 million in 2026.
  • Business Quant data shows ATAI's Liabilities and Shareholders Equity at $264.9 million in Q1 2026, $292.7 million in Q4 2025, and $159.4 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 10.96 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.32 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 9.18 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.56 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.10 Bn
10 AtaiBeckley 1.61 Bn 1.61 Bn - 239.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 264.79 Mn
Mar 31, 2026 264.88 Mn
Dec 31, 2025 292.72 Mn
Sep 30, 2025 239.82 Mn
Jun 30, 2025 189.20 Mn
Mar 31, 2025 195.78 Mn
Dec 31, 2024 159.39 Mn
Dec 31, 2024 159.39 Mn
Sep 30, 2024 197.52 Mn
Jun 30, 2024 215.78 Mn
Mar 31, 2024 269.12 Mn
Dec 31, 2023 293.48 Mn
Sep 30, 2023 308.22 Mn
Jun 30, 2023 253.60 Mn
Mar 31, 2023 280.72 Mn
Dec 31, 2022 305.44 Mn
Mar 31, 2022 383.73 Mn
Dec 31, 2021 4.76 Mn
Sep 30, 2021 885,000.00
Jun 30, 2021 885,000.00